QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.065268v1 310/1/230    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddy, D. S. Articles by Rogawski, M. A. Search for Related Content PubMed PubMed Citation Articles by Reddy, D. S. Articles by Rogawski, M. A.

NEUROPHARMACOLOGY

Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice

Department of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina (D.S.R.); Epilepsy Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (D.C.C., M.A.R.); and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas (B.W.O.)

Many of the biological actions of progesterone are mediated through the progesterone receptor (PR), a nuclear transcription factor. Progesterone is well recognized to protect against seizures in animal models. Although this activity has been attributed to the progesterone metabolite allopregnanolone, a GABA_A receptor-modulating neurosteroid with anticonvulsant properties, PRs could also play a role. Here, we used PR knockout (PRKO^-/-) mice bearing a targeted deletion of the PR gene that eliminates both isoforms of the PR to investigate the contribution of the PR to the anticonvulsant activity of progesterone. The protective activity of progesterone was examined in female and male homozygous PRKO mice and isogenic wild-type controls in the pentylenetetrazol (PTZ), maximal electroshock, and amygdala-kindling seizure models. In all three models, the anticonvulsant potency of progesterone was undiminished in PRKO mice compared with control mice. On the contrary, there was a substantial increase in the anticonvulsant potency of progesterone in the PTZ and kindling models. The antiseizure activity of progesterone in PRKO mice was reversed by pretreatment with finasteride, a 5-reductase inhibitor that blocks the metabolism of progesterone to allopregnanolone. Unlike progesterone, the neurosteroids allopregnanolone and allotetrahydrodeoxycorticosterone exhibited comparable anticonvulsant potency in PRKO and wild-type mice. The basis for the heightened progesterone responsiveness of PRKO mice is not attributable to pharmacokinetic factors, because the plasma allopregnanolone levels achieved after progesterone administration were not greater in the PRKO mice. These studies provide strong evidence that the PR is not required for the antiseizure effects of progesterone, which mainly occurs through its conversion to the neurosteroid allopregnanolone.

Address correspondence to: Dr. Doodipala S. Reddy, Department of Molecular Biomedical Sciences, North Carolina State University College of Veterinary Medicine, 4700 Hillsborough St., Raleigh, NC 27606. E-mail: samba_reddy{at}ncsu.edu

This article has been cited by other articles:

				P. Inquimbert, J.-L. Rodeau, and R. Schlichter Regional Differences in the Decay Kinetics of GABAA Receptor-Mediated Miniature IPSCs in the Dorsal Horn of the Rat Spinal Cord Are Determined by Mitochondrial Transport of Cholesterol J. Neurosci., March 26, 2008; 28(13): 3427 - 3437. [Abstract] [Full Text] [PDF]

				A. G. Herzog, K. M. Fowler, and For the NIH Progesterone Trial Study Group SENSITIVITY AND SPECIFICITY OF THE ASSOCIATION BETWEEN CATAMENIAL SEIZURE PATTERNS AND OVULATION Neurology, February 5, 2008; 70(6): 486 - 487. [Full Text] [PDF]